单期埋入式自体乳房再造(BABR)
该前瞻性系列由单术者历时8年完成156例患者共182个游离皮瓣乳房再造,其中埋入式69个、带皮岛113个,比较两组人口学、肿瘤学、再造细节、即刻并发症与修整手术。结果显示两组人口学与并发症无显著差异,埋入组51%无需进一步手术,而带皮岛组为29%。作者认为埋入式自体乳房再造安全且美观,可能实现单期再造,尤其联合保留乳头乳房切除术(肿瘤学安全时)或乳房缩小术式及必要时对侧对称化时。
要点
- 单术者8年前瞻性系列纳入156例患者182个游离皮瓣,埋入式69个、带皮岛113个。
- 两组人口学与并发症无显著差异,埋入组51%无需进一步手术,带皮岛组为29%。
- 作者认为埋入式自体乳房再造安全美观且可能单期完成,尤其联合保留乳头乳房切除术或乳房缩小术式及对侧对称化时。
核心结论
- 埋入式自体乳房再造是安全且美观的乳房再造选择,可能实现单期再造。
- 该优势尤其体现在联合保留乳头乳房切除术(肿瘤学安全时)或乳房缩小乳房切除术及必要时对侧对称化时。
- 进一步研究可包括患者报告结局指标与成本分析。
研究设计与样本
- 前瞻性系列比较埋入式与带皮岛游离皮瓣乳房再造,由单术者历时8年完成。
- 共156例患者182个游离皮瓣,埋入式69个、带皮岛113个。
- 记录并比较两组人口学、肿瘤学与再造细节、即刻并发症及修整手术。
主要发现
- 两组人口学与并发症无显著差异。
- 埋入组51%无需进一步手术,带皮岛组为29%。
临床怎么用
- 作者认为埋入式自体乳房再造是安全且美观的选择,可能实现单期再造,尤其联合保留乳头乳房切除术(肿瘤学安全时)或乳房缩小乳房切除术及必要时对侧对称化时。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Breast reconstructive standards are increasingly high oncologically, aesthetically, and practically. Autologous breast reconstruction remains the gold standard which, buried, after nipple-sparing mastectomy (where oncologically safe) or wise pattern reduction for large or ptotic patients, with contralateral symmetrisation where required, enables single-stage reconstruction. However, previous series report prohibitively high revision rates. This series prospectively compares a series of buried and non-buried free flaps for breast reconstruction. METHODS: All breast reconstructions with free autologous tissue transfer, buried or with a cutaneous paddle, conducted over 8 years by a single surgeon were included. Demographic, oncologic and reconstructive details, immediate complications and revision surgeries were recorded and compared between the two groups. RESULTS: A total of 182 free flaps were performed on 156 patients, 69 buried and 113 with cutaneous paddles. There were no significant demographic or complication differences between the two groups. Of the buried group, 51% did not require further surgery compared to 29% of the paddle group. CONCLUSIONS: Buried autologous breast reconstruction is a safe and aesthetic option for breast reconstruction, and potentially single stage. This is particularly true where it is combined with nipple-sparing mastectomy (where oncologically safe) or breast reduction mastectomy, and contralateral symmetrisation, where required. Further research could include patient reported outcome measures and cost analysis.
引用
- Rose V, Cooper L, Pafitanis G, et al. Single-stage buried autologous breast reconstruction (BABR). J Plast Reconstr Aesthet Surg. 2022. PMID: 35643594. doi:10.1016/j.bjps.2022.04.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。